Kelly Bertram

Senior Research Fellow, Department of Neuroscience

EmailKelly.Bertram@monash.edu

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Clinical Neurologist and Movement Disorders specialist with research interests in Parkinson's disease, Atypical Parkinsonism including Progressive Supranuclear Palsy and Multiple System Atrophy, and Dystonia.

Education/Academic qualification

Medicine, MBBS, University of Melbourne

External positions

Neurologist, Alfred Hospital

Research area keywords

Parkinson's disease
Atypical Parkinsonism
Dystonia
PSP
MSA
Tremor

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

5 Finished
8 Active

A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients.
Bertram, K. & Burn, K.
1/11/20 → 30/11/22
Project: Research
An Open-label Extension of Study M15-736 to Evaluate the Safety and Tolerability of 24-hour Daily Exposure of ABBV-951 in Subjects with Advanced Parkinson's Disease.
Bertram, K. & Burn, K.
20/10/20 → 31/12/24
Project: Research
An open-label extension of Study M15-741 to evaluate the safety and tolerability of 24-hour daily exposure of continuous subcutaneous infusion of ABBV-951 in subjects with Parkinson's disease.
Bertram, K., Fung, V. S. C., Hayes, M., Stell, R., Kimber, T. E. & Bonke, V.
6/10/20 → 31/12/25
Project: Research
Sodium Selenate as a Disease Modifying Treatment for Progressive Supranuclear Palsy (Sodium Selenate for PSP)
O'Brien, T., Bertram, K., Vivash, L., Evans, A. H., Kimber, T. E., O'Sullivan, J. D., Malpas, C., Fielding, J., Velakoulis, D. & Law, M.
1/06/20 → 31/05/25
Project: Research
A 52-Week, open-label, single-arm study to evaluate the safety and tolerability of 24-hour daily exposure of continuous subcutaneous infusion of ABBV-951 in subjects with Parkinson's disease
Bertram, K. & Burn, K.
22/11/19 → 30/11/21
Project: Research

18 Article
2 Letter

Impact of prefrontal intermittent theta-burst stimulation on working memory and executive function in Parkinson's disease: A double-blind sham-controlled pilot study
Hill, A. T., McModie, S., Fung, W., Hoy, K. E., Chung, S. W. & Bertram, K. L., 1 Jan 2020, In : Brain Research. 1726, 10 p., 146506.
Research output: Contribution to journal › Article › Research › peer-review

3 Citations (Scopus)
Dystonic crises in dopa-responsive dystonia induced by energy drinks
Fung, W. K. W. & Bertram, K. L., 1 Jun 2019, In : Practical Neurology. 19, 3, p. 268-269 2 p.
Research output: Contribution to journal › Article › Other › peer-review
Levodopa-carbidopa intestinal gel: is the naso-jejunal phase a redundant convention?
Vijiaratnam, N., Hewer, S., Varley, S., Paul, E., Bertram, K. L., Lee, W., Ligtermoet, M. K. & Williams, D. R., Apr 2018, In : Internal Medicine Journal. 48, 4, p. 469-471 3 p.
Research output: Contribution to journal › Article › Research › peer-review

6 Citations (Scopus)
Measuring disease progression and disability in orthostatic tremor
Vijiaratnam, N., Sirisena, D., Paul, E., Bertram, K. L. & Williams, D. R., Oct 2018, In : Parkinsonism & Related Disorders. 55, p. 138-140 3 p.
Research output: Contribution to journal › Article › Research › peer-review

3 Citations (Scopus)
Neck pain: What if it is not musculoskeletal?
Vijiaratnam, N., Williams, D. R. R. & Bertram, K., May 2018, In : Australian Journal of General Practice. 47, 5, p. 279-282 4 p.
Research output: Contribution to journal › Article › Other › peer-review

Open Access
File

3 Citations (Scopus)